Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 04 Dec 2024 | Laurent Muschel Acting Director-General | Pipeline presentation | — |
| 04 Dec 2024 | Laurent Muschel Acting Director-General | Pipeline presentation | SRC |
Mission & Goals
Shionogi is a research‑driven global biopharmaceutical company headquartered in Osaka, Japan, with more than 145 years of history. Guided by a strong values‑based culture and a long‑standing commitment to putting patients first, Shionogi is dedicated to improving patient health and advancing medical innovation worldwide. Shionogi Europe (Shionogi B.V.) is the European headquarters of Shionogi & Co., Ltd., headquartered in Amsterdam and operating across major European markets. In Europe, Shionogi focuses on the research, development and delivery of innovative pharmaceutical solutions, with particular expertise in infectious diseases, including antimicrobial resistance (AMR), as well as other hospital and specialty care areas and selected conditions that significantly impact quality of life.
EU Legislative Interests
General health strategy Revised pharma legislation Critical Medicines Act Biotech Act Union Preparedness Strategy ReArm Europe Other policies will be identified as appropriate
Communication Activities
EURACTIV Health Security event EP roundtable late 2020 Euro Health Forum - Gastein Euro Business Summit
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
ABPI (Association of the British Pharmaceutical Industry) AMR Action Fund AMR Industry Alliance BEAM Alliance BIO (Biotechnology Industry Organization) Brussels Resilience Forum (Organized by FIPRA) CAIC (Canadian Antimicrobial Innovation Coalition) Deutsches Netzwerk gegen Antimikrobielle Resistenzen (German Network against Antimicrobial Resistance) EUCOPE (European Confederation of Pharmaceutical Entrepreneurs) EUPATI (The European Patients’ Academy) EURORDIS Farmindustria GCOA (Global Coalition on Aging) HGPI (Health and Global Policy Institute) IFPMA (International Federation of Pharmaceutical Manufacturers Associations) International Pompe Association Japan Business Council of Europe - Health Study Group (JBCE) JCIE (Japan Center for International Exchange) JPMA (Japan Pharmaceutical Manufacturers Association) Paddington Life Sciences Swiss RTA (Roundtable on Antibiotics) UK PoMpe Support network WEF UCARES (World Economic Forum, Unified Coalition for the Antimicrobial Resistance Response)
Organisation Members
Corporate structure and affiliation Shionogi BV is the European regional headquarters of Shionogi & Co., Ltd., a global pharmaceutical company headquartered in Osaka, Japan. Shionogi BV coordinates activities across Shionogi’s European affiliates and operates as part of the global Shionogi group. Strategic direction, including global policy and corporate affairs priorities, is aligned with Shionogi & Co., Ltd. A full list of European affiliates can be found here: https://www.shionogi.com/eu/en/about-shionogi/global-affiliates-and-locations.html